The deal was first announced in September. Intracept will be added to Boston Scientific’s chronic pain portfolio that includes spinal cord stimulation, radiofrequency ablation and an interspinous spacer procedure. Intracept recently earned national coverage from Anthem Blue Cross Blue Shield and Humana
The transaction includes an upfromt cash payment of $850 million and contingent payments based on sales over three years.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
